This inventor holds 1 USPTO granted patent. Top assignee: Glenmark Pharmaceuticals S.a.. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: Usha Karaunakaran: Innovator in Pharmaceutical Chemistry
Introduction
Usha Karaunakaran is a prominent inventor based in Mumbai, India. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for medical applications. Her work focuses on addressing inflammatory and allergic disorders through innovative chemical solutions.
Latest Patents
Usha Karaunakaran holds a patent for "Heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them." This invention relates to novel heterocyclic compounds, their analogs, tautomers, regioisomers, stereoisomers, enantiomers, diastereomers, polymorphs, and pharmaceutically acceptable salts. More specifically, it includes Phosphodiesterase type 4 (PDE4) inhibitors, which are crucial for developing effective treatments for various health conditions.
Career Highlights
Usha has established herself as a key figure in the pharmaceutical industry, working with Glenmark Pharmaceuticals S.A. Her expertise in the synthesis and application of heterocyclic compounds has positioned her as a valuable asset in the research and development sector.
Collaborations
Throughout her career, Usha has collaborated with notable colleagues, including Balasubramanian Gopalan and Laxmikant Atmaram Gharat. These partnerships have enhanced her research capabilities and contributed to the advancement of innovative pharmaceutical solutions.
Conclusion
Usha Karaunakaran's contributions to pharmaceutical chemistry exemplify the impact of innovative thinking in addressing complex medical challenges. Her work continues to inspire future advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
